These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21890535)

  • 1. Plasma calprotectin levels reflect disease severity in patients with chronic heart failure.
    Jensen LJ; Kistorp C; Bjerre M; Raymond I; Flyvbjerg A
    Eur J Prev Cardiol; 2012 Oct; 19(5):999-1004. PubMed ID: 21890535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
    Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
    Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure.
    Eleuteri E; Di Stefano A; Tarro Genta F; Vicari C; Gnemmi I; Colombo M; Mezzani A; Giannuzzi P
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):607-14. PubMed ID: 21450636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma calprotectin predicts mortality in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Jensen LJ; Pedersen S; Bjerre M; Mogelvang R; Jensen JS; Flyvbjerg A
    J Interv Cardiol; 2010 Apr; 23(2):123-9. PubMed ID: 20337863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
    Genth-Zotz S; Bolger AP; Kalra PR; von Haehling S; Doehner W; Coats AJ; Volk HD; Anker SD
    Int J Cardiol; 2004 Sep; 96(3):397-401. PubMed ID: 15301893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Defensins and outcome in patients with chronic heart failure.
    Christensen HM; Frystyk J; Faber J; Schou M; Flyvbjerg A; Hildebrandt P; Raymond I; Klausen TW; Kistorp C
    Eur J Heart Fail; 2012 Apr; 14(4):387-94. PubMed ID: 22357441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide is upregulated and associated with mortality in patients with chronic heart failure.
    Yu J; Pan W; Shi R; Yang T; Li Y; Yu G; Bai Y; Schuchman EH; He X; Zhang G
    Can J Cardiol; 2015 Mar; 31(3):357-63. PubMed ID: 25746025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function.
    Erbs S; Höllriegel R; Linke A; Beck EB; Adams V; Gielen S; Möbius-Winkler S; Sandri M; Kränkel N; Hambrecht R; Schuler G
    Circ Heart Fail; 2010 Jul; 3(4):486-94. PubMed ID: 20430934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
    Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
    Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low atrial fibrillatory rate is associated with poor outcome in patients with mild to moderate heart failure.
    Platonov PG; Cygankiewicz I; Stridh M; Holmqvist F; Vazquez R; Bayes-Genis A; McNitt S; Zareba W; de Luna AB;
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):77-83. PubMed ID: 22235036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
    Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
    J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.